Shares of Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) dropped 10.9% during mid-day trading on Thursday . The company traded as low as $0.55 and last traded at $0.55. Approximately 13,834 shares were traded during mid-day trading, an increase of 361% from the average daily volume of 3,001 shares. The stock had previously closed at $0.62.
Starpharma Trading Down 10.9 %
The company has a quick ratio of 4.58, a current ratio of 4.94 and a debt-to-equity ratio of 0.07. The business has a 50 day moving average price of $0.67 and a two-hundred day moving average price of $0.65.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Recommended Stories
- Five stocks we like better than Starpharma
- What Are Trending Stocks? Trending Stocks Explained
- Micron Stock Under $100: Seize the AI-Driven Upside
- Why is the Ex-Dividend Date Significant to Investors?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What is a Dividend King?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
